Steven Yea
Overview
Explore the profile of Steven Yea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim D, Chung H, Liu W, Jeong K, Ozmen T, Ozmen F, et al.
NPJ Precis Oncol
. 2025 Jan;
9(1):3.
PMID: 39755818
Upregulation of Cyclin E1 and subsequent activation of CDK2 accelerates cell cycle progression from G1 to S phase and is a common oncogenic driver in gynecological malignancies. WEE1 kinase counteracts...
2.
Bates K, Vathiotis I, MacNeil T, Shabbir Ahmed F, Aung T, Katlinskaya Y, et al.
BMC Cancer
. 2023 Mar;
23(1):220.
PMID: 36894898
Background: CD40, a TNF receptor family member, is expressed by a variety of immune cells and is involved in the activation of both adaptive and innate immune responses. Here, we...
3.
DeNicola M, Pullarkat S, Yea S, Rao N, Yang L, Tirado C
J Assoc Genet Technol
. 2015 Jun;
40(1):22-4.
PMID: 26030621
Hyperdiploidy has been described in a variety of malignancies including acute lymphoblastic leukemia and plasma cell myeloma, in which the abnormality is associated with a very good prognosis. Herein, we...
4.
Said J, Lones M, Yea S
Adv Anat Pathol
. 2014 Apr;
21(3):160-5.
PMID: 24713985
Burkitt lymphoma (BL) is the most common non-Hodgkin lymphoma in children and adolescents, but at least 30% of cases occur in patients older than 60 years, and the absolute number...
5.
Yea S, Anthony M, Yuan S
J Clin Anesth
. 2012 Sep;
24(6):505-6.
PMID: 22986321
No abstract available.
6.
Lee U, Ghiassi-Nejad Z, Paris A, Yea S, Narla G, Walsh M, et al.
FEBS Lett
. 2010 Feb;
584(5):1006-10.
PMID: 20116377
The tumor suppressor Kruppel-like factor 6 (KLF6) is frequently inactivated in hepatocellular carcinoma (HCC). To unearth downstream transcriptional targets of KLF6, cDNA microarray analysis of whole liver was compared between...
7.
Guo J, Hong F, Loke J, Yea S, Lim C, Lee U, et al.
J Biol Chem
. 2009 Dec;
285(8):5428-37.
PMID: 20022962
We recently identified a missense single nucleotide polymorphism (SNP) in DDX5 (rs1140409, p.S480A) that enhances the risk of developing cirrhosis. DDX5 is an ATP-dependent RNA helicase and transcriptional modulator. We...
8.
Newell P, Toffanin S, Villanueva A, Chiang D, Minguez B, Cabellos L, et al.
J Hepatol
. 2009 Aug;
51(4):725-33.
PMID: 19665249
Background/aims: The success of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) has focused interest on the role of Ras signaling in this malignancy. We investigated the molecular alterations...
9.
Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, et al.
Hepatology
. 2008 Dec;
49(3):960-8.
PMID: 19085953
Unlabelled: In a recent study, a single nucleotide polymorphism (SNP) of the Toll-like receptor 4 (TLR4) gene (c.1196C>T [rs4986791, p.T399I]) emerged as conferring protection from fibrosis progression compared to a...
10.
Villanueva A, Chiang D, Newell P, Peix J, Thung S, Alsinet C, et al.
Gastroenterology
. 2008 Oct;
135(6):1972-83, 1983.e1-11.
PMID: 18929564
Background & Aims: The advent of targeted therapies in hepatocellular carcinoma (HCC) has underscored the importance of pathway characterization to identify novel molecular targets for treatment. We evaluated mTOR signaling...